Last reviewed · How we verify
NCT04657445
EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY
trial testing visual analogue scale in Olfactory and Taste Dysfunction in SARS-CoV2 Infection in 100 participants. Completed in 30 June 2021.
31 May 2021
Quick facts
| Lead sponsor | University Hospital, Ioannina |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 17 November 2020 |
| Primary completion | 31 May 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- visual analogue scale
Conditions studied
- Olfactory and Taste Dysfunction in SARS-CoV2 Infection — all drugs for Olfactory and Taste Dysfunction in SARS-CoV2 Infection →
Sponsor
University Hospital, Ioannina
Who can join
18 and older, any sex, with Olfactory and Taste Dysfunction in SARS-CoV2 Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational data and recording study. The aim of our study is to investigate the effect of SARS-COV2 infection on patients' sense of smell and taste, through quality control measurements using optic analogue scale (VAS) in hospitalized and in home-quarantined patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Visual Analogue Scale for the Evaluation of Olfactory and Gustatory Dysfunction of COVID-19 Patients in Northwestern Greece.
Zarachi A, Lianou AD, Pezoulas V, Komnos I, et al · · 2023 · cited 2× · PMID 37090302 · DOI 10.7759/cureus.36413
Verify or expand the search:
- PubMed search for NCT04657445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of visual analogue scale
Trials testing the same drug.
- NCT04231955 — Comparison of Different Pain Rating Scales in Patients With Symptomatic Teeth · NA · completed
- NCT03890042 — Dienogest for Treatment of Adenomyotic Uteri · NA · completed
Other University Hospital, Ioannina trials
Trials by the same sponsor.
- NCT07372521 — Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontro · not yet recruiting
- NCT06081205 — Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease · recruiting
- NCT05734248 — Fractional Laser Drug Delivery of a Local Anesthetic · NA · completed
- NCT06115213 — The North Kynouria Project · NA · unknown
- NCT04787510 — COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04657445 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ioannina
- Last refreshed: 13 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04657445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing